Literature DB >> 20094816

The molecular basis of carcinogenesis in Barrett's esophagus.

Rhonda F Souza1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20094816      PMCID： PMC2873060          DOI： 10.1007/s11605-009-1145-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  23 in total

1.  Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression.

Authors:  A Couvelard; F Paraf; V Gratio; J Y Scoazec; D Hénin; C Degott; J F Fléjou
Journal:  J Pathol       Date:  2000-09       Impact factor: 7.996

2.  Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population.

Authors:  Agnieszka M Rygiel; Jantine W P M van Baal; Francesca Milano; Kenneth K Wang; Febo J ten Kate; Paul Fockens; Wilda D Rosmolen; Jacques J G H M Bergman; Maikel P Peppelenbosch; Kausilia K Krishnadath
Journal:  Cancer       Date:  2007-05-15       Impact factor: 6.860

3.  Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation.

Authors:  V Jon Wongsurawat; Jennifer C Finley; Patricia C Galipeau; Carissa A Sanchez; Carlo C Maley; Xiaohong Li; Patricia L Blount; Robert D Odze; Peter S Rabinovitch; Brian J Reid
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-03       Impact factor: 4.254

4.  Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens.

Authors:  Agnieszka M Rygiel; Francesca Milano; Febo J Ten Kate; John G de Groot; Maikel P Peppelenbosch; Jacques J G H M Bergman; Kauslillia K Krishnadath
Journal:  Genes Chromosomes Cancer       Date:  2008-05       Impact factor: 5.006

5.  Fas ligand expression in esophageal carcinomas and their lymph node metastases.

Authors:  M Younes; M R Schwartz; A Ertan; D Finnie; A Younes
Journal:  Cancer       Date:  2000-02-01       Impact factor: 6.860

6.  Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.

Authors:  B J Reid; L J Prevo; P C Galipeau; C A Sanchez; G Longton; D S Levine; P L Blount; P S Rabinovitch
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

7.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

Authors:  B J Reid; D S Levine; G Longton; P L Blount; P S Rabinovitch
Journal:  Am J Gastroenterol       Date:  2000-07       Impact factor: 10.864

8.  Abnormal expression of the E-cadherin-catenin complex in dysplastic Barrett's oesophagus.

Authors:  J P Seery; K N Syrigos; A J Karayiannakis; A Valizadeh; M Pignatelli
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

9.  Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.

Authors:  Dennis L Chao; Carissa A Sanchez; Patricia C Galipeau; Patricia L Blount; Thomas G Paulson; David S Cowan; Kamran Ayub; Robert D Odze; Peter S Rabinovitch; Brian J Reid
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

10.  NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.

Authors:  Patricia C Galipeau; Xiaohong Li; Patricia L Blount; Carlo C Maley; Carissa A Sanchez; Robert D Odze; Kamran Ayub; Peter S Rabinovitch; Thomas L Vaughan; Brian J Reid
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069
View more
  2 in total

Review 1.  Management strategies of Barrett's esophagus.

Authors:  Giovanni D De Palma
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

2.  Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells.

Authors:  Christiane D Fichter; Corinna Herz; Claudia Münch; Oliver G Opitz; Martin Werner; Silke Lassmann
Journal:  BMC Cell Biol       Date:  2011-04-06       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.